Posts tagged with: pharmaceuticals

The Manhattan Institute’s Proxy Monitor project is aimed at “shedding light on the influence of shareholder proposals on corporations.” It provides a thorough analysis of proposals made from 2008 – 2011 by activist investors — and believe it or not, only 35 percent of those proposals were related to corporate governance. Most of the shareholder proposals that these companies deal with are attempts to direct the company in a more green or pacific or fair direction, and they come from small shareholders who do this to dozens of companies.

Read more on Shareholder Activism on the Rise – from Nuns and Unitarians…

Jordan J. Ballor
posted by on Wednesday, January 24, 2007

Last night the President spoke of “the challenge of entitlements” and said that “Social Security and Medicare and Medicaid are commitments of conscience — and so it is our duty to keep them permanently sound.”

Read more on Negotiating Entitlements…

Kevin Schmiesing
posted by on Thursday, September 7, 2006

An interesting debate is going on over at Mere Comments. The main thread has to do with the morality of the Bush Administration’s approval of over-the-counter sales of the morning-after pill and the implications for Pennsylvania’s U.S. Senate race. Leaving those issues aside, I was struck by a comment from “Daniel C.”, claiming that the problem really presents an “excellent case for dismantling the Food & Drug Administration.”

Read more on Abolish the FDA?…

At least, the title of this post is typical of the mantra against the practices of drug pharmaceutical companies, according to Peter W. Huber’s “Of Pills and Profits: In Defense of Big Pharma,” in Commentary magazine (HT: Arts & Letters Daily).

Read more on ‘We get Viagra. They get malaria.’…

Acton PowerBlog RSS

Google Plus

Twitter Feed

Facebook Fan Page

Support the Acton Institute

The Acton Institute is funded through the generous contributions of individuals such as yourself. Learn more about how you can advance the cause of freedom and virtue.